These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5331137)

  • 1. Inhibitors of dihydrofolic acid reductase in the therapy of infectious diseases.
    Hitchings GH
    Bibl Nutr Dieta; 1966; 8():226-37. PubMed ID: 5331137
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible enzyme inhibitors. 88. Differential irreversible inhibition of dihydrofolic reductase from different species.
    Baker BR; Jordaan JH
    J Pharm Sci; 1967 May; 56(5):660-1. PubMed ID: 5340324
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo antibacterial activity of diaveridine-sulfonamide combinations.
    Carroll PT; Robb CA; Tippett LO; Langston JB
    Invest Urol; 1971 Jul; 9(1):21-4. PubMed ID: 4935215
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
    Baker BR; Lourens GJ; Meyer RB; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):67-73. PubMed ID: 5763043
    [No Abstract]   [Full Text] [Related]  

  • 5. Analogs of tetrahydrofolic acid XXV. 2,4-Diamino-6-phenethylpteridine, an inhibitor of dihydrofolic reductase.
    Baker BR; Ho BT
    J Pharm Sci; 1965 Sep; 54(9):1261-5. PubMed ID: 5881216
    [No Abstract]   [Full Text] [Related]  

  • 6. Analogs of tetrahydrofolic acid XXIV. Further observations on the mode of pyrimidyl binding to dihydrofolic reductase and thymidylate synthetase by the 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol type of inhibitor.
    Baker BR; Santi DV
    J Pharm Sci; 1965 Sep; 54(9):1252-7. PubMed ID: 5881214
    [No Abstract]   [Full Text] [Related]  

  • 7. Analogs of tetrahydrofolic acid XX. Effects of modification of the bridge between the pyrimidyl and phenyl moieties of 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol on inhibition of dihydrofolic reductase and thymidylate synthetase II.
    Baker BR; Ho BT
    J Pharm Sci; 1965 Aug; 54(8):1187-90. PubMed ID: 5882225
    [No Abstract]   [Full Text] [Related]  

  • 8. Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
    Wagner CR; Benkovic SJ
    J Med Chem; 1992 Jul; 35(15):2912-5. PubMed ID: 1495020
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on condensed pyrimidine systems. XXV. 2,4-diaminopyrido[2,3-d]pyrimidines. Biological data.
    Hurlbert BS; Ferone R; Herrmann TA; Hitchings GH; Barnett M; Bushby SR
    J Med Chem; 1968 Jul; 11(4):711-7. PubMed ID: 4970356
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the 2,4-diamino-6-substituted quinazolines. III. The capacity of sulfadiazine to enhance the activities of WR-158,122 and WR-159,412 against infections with various drug-susceptible and drug-resistant strains of Plasmodium falciparum and Plasmodium vivax in owl monkeys.
    Schmidt LH
    Am J Trop Med Hyg; 1979 Sep; 28(5):808-18. PubMed ID: 114066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible enzyme inhibitors. LXXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VII. Derivatives of 2,4-diaminopyrimidine. I.
    Baker BR; Jackson GD; Meyer RB
    J Pharm Sci; 1967 May; 56(5):566-70. PubMed ID: 6040577
    [No Abstract]   [Full Text] [Related]  

  • 12. Irreversible enzyme inhibitors. LXXXIV. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IX. Derivatives of 2,4-diaminopyrimidine. 3.
    Baker BR; Meyer RB
    J Pharm Sci; 1967 May; 56(5):570-6. PubMed ID: 6032766
    [No Abstract]   [Full Text] [Related]  

  • 13. Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):34-7. PubMed ID: 5237172
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of inhibitors in studies of comparative enzymology.
    Hitchings GH
    Fed Proc; 1967; 26(4):1078-81. PubMed ID: 6028773
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitor binding analysis of dihydrofolate reductases from various species.
    Burchall JJ; Hitchings GH
    Mol Pharmacol; 1965 Sep; 1(2):126-36. PubMed ID: 4378654
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on dihydrofolic reductase, II. The activation of dihydrofolic reductase from chicken liver by iodine.
    Kaufman BT
    Proc Natl Acad Sci U S A; 1966 Aug; 56(2):695-700. PubMed ID: 4381832
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible enzyme inhibitors. LXXI. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. V. Derivatives of 6-phenylpyrimidine.
    Baker BR; Shapiro HS
    J Pharm Sci; 1967 Jan; 56(1):33-8. PubMed ID: 6030490
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new cytochemical method for the study of the tetrahydrofolatereductase activity in Plasmodium berghei: analysis of the effect of specific inhibitors].
    Gerzeli G; Polver Pde P
    Riv Parassitol; 1969 Mar; 30(1):19-26. PubMed ID: 5405877
    [No Abstract]   [Full Text] [Related]  

  • 19. Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):26-33. PubMed ID: 5237171
    [No Abstract]   [Full Text] [Related]  

  • 20. Water medication with sulphadiazine and trimethoprin for the treatment of staphylococcal osteomyelitis in poultry.
    Johnston RE
    Aust Vet J; 1972 Oct; 48(10):578-9. PubMed ID: 4649720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.